Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This British Association for Psychopharmacology guideline replaces the original version published in 2010, and contains updated information and recommendations. A consensus meeting was held in London in October 2017 attended by recognised experts and advocates in the field. They were asked to provide a review of the literature and identification of the standard of evidence in their area, with an emphasis on meta-analyses, systematic reviews and randomised controlled trials where available, plus updates on current clinical practice. Each presentation was followed by discussion, aiming to reach consensus where the evidence and/or clinical experience was considered adequate, or otherwise to flag the area as a direction for future research. A draft of the proceedings was circulated to all speakers for comments, which were incorporated into the final statement.

Original publication

DOI

10.1177/0269881119855343

Type

Journal article

Journal

J Psychopharmacol

Publication Date

08/2019

Volume

33

Pages

923 - 947

Keywords

Sleep disorders, circadian rhythm disorders, evidence-based treatment, guidelines, insomnia, parasomnias, Chronobiology Disorders, Consensus, Evidence-Based Medicine, Humans, London, Parasomnias, Psychopharmacology, Randomized Controlled Trials as Topic, Sleep Initiation and Maintenance Disorders